Intrinsic defect of the immune system in children with Down syndrome: A review

Clinical and Experimental Immunology

Volumn 156, Issue 2, 2009, Pages 189-193

  Kusters, M A A ^b   Verstegen, R H J ^b   Gemen, E F A ^a   De Vries, E ^a,b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Department of Paediatrics ^*  (Netherlands)

Author keywords

Children; Down syndrome; Immune system; Primary immunodeficiency

Indexed keywords

AGING; ALZHEIMER DISEASE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CLINICAL FEATURE; DISEASE ASSOCIATION; DOWN SYNDROME; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INNATE IMMUNITY; L CELL; NATURAL KILLER CELL; NERVOUS SYSTEM; PRIORITY JOURNAL; THYMUS;

AGING, PREMATURE; ANTIBODY FORMATION; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; HUMANS; IMMUNE SYSTEM; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; THYMUS GLAND;

EID: 64649097543     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03890.x     Document Type: Article

References (74)

1. Hassold T, Jacobs P. Trisomy in man. Ann Rev Genet 1984 18 : 69 97.
2. Lott I. Down's syndrome, aging, and Alzheimer's disease: a clinical review. Ann NY Acad Sci 1982 396 : 15 27.
3. Tolksdorf M, Wiedemann H. Clinical aspects of Down's syndrome from infancy to adult life. Hum Genet Suppl 1981 2 : 3 31.
4. Miller RW. Neoplasia and Down's syndrome. Ann NY Acad Sci 1970 171 : 637.
5. Fraumeni J, Manning M, Mitus W. Acute childhood leukemia: epidemiological study by cell type in 1263 cases at the Children's Cancer Research Foundation in Boston. J Natl Cancer Inst 1971 46 : 461 70.
6. Fabia J, Droletter M. Malformations and leukemia in children with Down syndrome. Pediatrics 1970 45 : 60 70.
7. Goldacre M, Wotton C, Seagroatt V et al. Cancers and immune related diseases associated with Down syndrome: a record linkage study. Arch Dis Child 2004 89 : 1014 17.
8. Yang Q, Rasmussen S, Friedman J. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002 359 : 1019 25.
9. Sanchez-Albisua I, Storm W, Wascher I et al. How frequent is celiac disease in Down syndrome? Eur J Pediatr 2002 161 : 683 4.
10. Karlsson B, Gustafsson J, Hedov G et al. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998 79 : 242 5.
11. Anwar A, Walker J, Frier B. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med 1998 15 : 160 3.
12. Garrison M, Jeffries H, Christakis D. Risk of death for children with Down syndrome and sepsis. J Pediatr 2005 147 : 748 52.
13. Burgio G, Lanzavecchia A, Maccario R et al. Immunodeficiency in Down's syndrome: T lymphocyte subset imbalance in trisomic children. Clin Exp Immunol 1978 33 : 298 301.
14. Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr 1975 64 : 322.
15. Burgio G, Ugazio A, Nespoli L et al. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol 1975 5 : 600 3.
16. Levin S, Schlesinger M, Handzel Z. Thymic deficiency in Down's syndrome. Pediatrics 1979 63 : 80 3.
17. Gatti R, Good R. Aging, immunity and malignancy. Geriatrics 1970 25 : 158 68.
18. Ginaldi L, De Martinis M, D'Ostilio A et al. The immune system in the elderly: II. Specific cellular immunity. Immunol Res 1999 20 : 109 15.
19. Ram J. Aging and immunological phenomena - a review. J Gerontol 1967 22 : 92 107.
20. Pawelec G, Barnett Y, Forsey R et al. T cells and aging, January 2002 update. Front Biosci 2002 1 : 1056 83.
21. Cossarizza A, Monti D, Montagnani G et al. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T lymphocyte subsets, and cells with natural killer markers. Am J Med Genet 1990 7 : 213 18.
22. Cuadrado E, Barrena M. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996 78 : 209 14.
23. Roat E, Prada N, Lugli E. Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome. Rejuv Res 2008 11 : 573 83.
24. Cossarizza A. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 1991 77 : 1263 70.
25. Hingh Y, Van der Vossen P, Gemen E et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005 147 : 744 7.
26. Murphy M, Epstein L. Down syndrome (trisomy 21) thymuses have a decrease proportion of cells expressing high levels of TCRalpha, beta and CD3. Clin Immunol Immunopathol 1990 55 : 453 67.
27. Murphy M, Friend D, Pike-Nobile L et al. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. J Immunol 1992 149 : 2506 12.
28. Ugazio A, Maccario R, Notarangelo L et al. Immunology of Down syndrome: a review. Am J Med Genet Suppl 1990 7 : 204 12.
29. Sansoni P, Vescovini R, Fagnoni F et al. The immune system in extreme longevity. Exp Gerontol 2008 43 : 61 5.
30. Nespoli L, Burgio G, Ugazio A et al. Immunological features of Down's syndrome: a review. J Int Dis Res 1993 37 : 543 51.
31. Larocca L, Lauriola L, Raneletti F. Morphological and immunohistochemical study of Down syndrome thymus. Am J Med Genet 1990 7 : 225 30.
32. Musiani P, Valitutti S, Castellino F. Intrathymic deficient expansion of T cell precursors in Down syndrome. Am J Med Genet 1990 7 : 219 24.
33. Yamaguchi T, Murakami A, Fukahara K et al. Changes in T-cell receptor subsets after cardiac surgery in children. Surg Today 2000 30 : 875 8.
34. Habermehl P, Knuf M, Kampmann C et al. Changes in lymphocyte subsets after cardiac surgery in children. Eur J Pediatr 2003 162 : 15 21.
35. Eysteinsdottir J, Freysdottir J, Haraldsson A et al. The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in life. Clin Exp Immunol 2004 136 : 349 55.
36. Murphy M, Lempert M, Epstein L. Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet 1990 7 : 234 7.
37. Murphy M, Epstein L. Down syndrome peripheral blood contains phenotypically mature CD3 TCRalphabeta cells but abnormal proportions of TCRgammadelta, TCRalphabeta and CD4+45RA+ cells: evidence for an inefficient release of mature T cells by DS thymus. Clin Immunol Immunopathol 1992 62 : 245 51.
38. Barrena M, Echaniz P, Garcia-Serrano C et al. Imbalance of the CD4+ subpopulations expressing CD45RA and CD29 antigens in the peripheral blood of adults and children with Down syndrome. Scand J Immunol 1993 38 : 323 6.
39. Lavi R, Kamchaisatian W, Sleasman J et al. Thymic output markers indicate immune dysfunction in DiGeorge syndrome. J Allergy Clin Immunol 2006 118 : 1184 6.
40. Prada N, Nasi M, Troiano L et al. Direct analysis of thymic function in children with Down's syndrome. Immun Aging 2005 2 : 1 8.
41. Saule P, Trauet J, Dutriez V et al. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev 2006 127 : 274 81.
42. Junge S, Kloeckener-Gruissem B, Zufferey R et al. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Eur J Immunol 2007 37 : 3270 80.
43. Cossarizza A, Ortolaini C, Paganelli R et al. CD45 isoform expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev 1996 86 : 173 95.
44. Shearer WT, Rosenblatt HM, Gelman RS et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS clinical trials group P1009 study. J Allergy Clin Immunol 2003 112 : 973 80.
45. Agarwal S, Blumberg B, Gerstley B et al. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome. J Clin Invest 1970 49 : 161 9.
46. Gershwin M, Crinella F, Castles J et al. Immunologic characteristics of Down's syndrome. J Ment Def Res 1977 21 : 237 49.
47. Rigas D, Elsasser P, Hecht F. Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose- and time-response curves and relation to cellular immunity. Int Arch Allergy Immunol 1970 39 : 587 608.
48. Malago W, Sommer C, Cistia Andrade DC et al. Gene expression profile of human Down syndrome leukocytes. Croat Med J 2005 46 : 647 56.
49. Sustrova M, Sarikova V. Down's syndrome - effect of increased gene expression in chromosome 21 on the function of the immune and nervous system. Bratisl Lek Listy 1997 98 : 221 8.
50. Li C, Guo M, Salas M et al. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 2006 7.
51. Peled-Kamar M, Lotem J, Okon E et al. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome. EMBO J 1995 16 : 4985 93.
52. Avanzini M, Monafo V, De Amici M et al. Humoral immunodeficiency in Down syndrome: serum IgG subclass and antibody response to hepatitis B vaccine. Am J Med Genet 1990 7 : 231 3.
53. McMillan B, Hanson R, Colubjatnikov G et al. The effect of institutionalisation on elevated IgD and IgG levels in patients with Down's syndrome. J Ment Defic Res 1975 19 : 209 23.
54. Costa-Carvalho B, Martinez R, Dias A et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res 2006 39 : 1587 92.
55. Epstein L, Philip R. Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21). Oncol Immunol Down Syndr 1987 163 82.
56. Ferreira C, Leite J, Taniguchi A et al. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr 2004 39 : 337 40.
57. Garcia Bengoechea M, Cortes B. Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down syndrome. A controlled study. Med Clin 1990 94 : 528 30.
58. Livolte S, Mattina A. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down syndrome. Child Nerv Syst 1996 12 : 100 2.
59. McKay E, Hems G, Massie A et al. Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome. J Hyg 1978 81 : 25 30.
60. Troisi C, Heidelberg D, Hollinger F. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. JAMA 1985 254 : 3196 9.
61. Storm W. Prevalence and diagnostic significance of gliadin antibodies in children with Down syndrome. Eur J Pediatr 1990 149 : 833 4.
62. Franceschi C, Licastro F, Paolucci P. T and B lymphocyte subsets in Down's syndrome: a study of non-institutionalized subjects. J Ment Defic 1987 22 : 179 91.
63. Lockitch G. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 1987 22 : 536 40.
64. Zizka Z, Calda P, Fait T. Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome. Fetal Diagn Ther 2006 21 : 510 14.
65. Pilliero L, Sanford A, McDonald-McGinn D et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004 103 : 1020 5.
66. Chinen J, Rosenblatt H, O'Brian Smith E et al. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003 111 : 573 9.
67. Jawad A, McDonald-McGinn D, Zackai E et al. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 2001 139 : 715 23.
68. Kourtis A, Ibegbu C, Nahmias A et al. Early progression of disease in HIV-infected infants with thymic dysfunction. NEJM 1996 335 : 1431 6.
69. Franciotta D, Verri A, Zardini E et al. Interferon-gamma and interleukin-4-producing T cells in Down's syndrome. Neurosci Lett 2006 395 : 67 70.
70. Barradas C, Charlton J, Mendoca P et al. IgG subclasses serum concentrations in a population of children with Down syndrome: comparative study with siblings and general population. Allergol Immunopathol 2002 30 : 57 61.
71. De Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 2006 145 : 204 14.
72. Liston A, Enders A, Siggs O. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat Rev Immunol 2008 8 : 545 58.
73. Lopes-da-Silva S, Rizzo L. Autoimmunity in common variable immunodeficiency. J Clin Immunol 2008 28 : 46 55.
74. Philip R, Berger A, McManus N et al. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol 1986 136 : 1661 7.